INTERNATIONAL PATENT: ASTRAZENECA AB FILES APPLICATION FOR "COMBINATION OF ZIBOTENTAN AND DAPAGLIFLOZIN FOR USE FOR THE TREATMENT OF HYPERTENSION"

GENEVA, Aug. 11 -- ASTRAZENECA AB (SE-151-85Sodertalje) filed a patent application (PCT/IB2025/051038) for "COMBINATION OF ZIBOTENTAN AND DAPAGLIFLOZIN FOR USE FOR THE TREATMENT OF HYPERTENSION" on Jan 30, 2025. With publication no. WO/2025/163559, the details related to the patent application was published on Aug 07, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): AMBERY, Philip (ASTRAZENECA ABSE-151-85 Sodertalje), GREASLEY, Peter (ASTRAZENECA ABSE-151-85 Sodertalje)

Abstract: Methods for treating uncontrolled hypertension, resistant hypertension, systemic hypertension, and pulmonary hy...